Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9BXA7
UPID:
TSSK1_HUMAN
Alternative names:
Serine/threonine-protein kinase 22A
Alternative UPACC:
Q9BXA7; B2R8D9
Background:
Testis-specific serine/threonine-protein kinase 1, also known as Serine/threonine-protein kinase 22A, plays a crucial role in spermatid development. It specifically phosphorylates 'Ser-288' of TSKS, facilitating the late stages of spermatogenesis and the reconstruction of the cytoplasm. This protein is essential for the transformation of a ring-shaped structure around the base of the flagellum, originating from the chromatoid body.
Therapeutic significance:
Understanding the role of Testis-specific serine/threonine-protein kinase 1 could open doors to potential therapeutic strategies.